{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:38:41Z","timestamp":1784155121727,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA052673"],"award-info":[{"award-number":["K01DA052673"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:p>Chronic pain is an individual experience with physical and psychological dimensions. Ketamine is used in sub-anesthetic doses to treat chronic pain. We describe a proposed multidisciplinary approach with combined treatment of low-dose ketamine and pain-focused psychological and somatic therapies to benefit quality of life of disabled chronic pain patients. Beyond pain reduction, within the biopsychosocial approach, the treatment aims to achieve reduced suffering and improved pain management, functionality, and quality of life. Adopting a multidisciplinary approach can minimize exposure to ketamine and maintain a conservative ketamine dosing regimen. In this way, ketamine is not only used for the analgesic effects, but also to facilitate internal psychological processes of body-mind integration related to the pain identity and trauma. We illustrate the presented treatment approach with three cases of patients treated in a private clinic in Florida, United States. We describe the patients' original injury, ketamine and adjunct psychological and somatic therapies regimen, and short and longer-term outcomes from the patient's perspective. These results are preliminary, require replication with validated measures, and represent an opportunity for additional research and hypothesis formation. More clinical research on ketamine and adjunct therapies for chronic pain conditions is warranted to advance treatment options.<\/jats:p>","DOI":"10.3389\/fpain.2025.1675821","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:31:02Z","timestamp":1768890662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Treating chronic pain with low dose ketamine and adjunct therapies within a biopsychosocial approach: a case series"],"prefix":"10.3389","volume":"6","author":[{"given":"Shahar","family":"Almog","sequence":"first","affiliation":[{"name":"Department of Health Education and Behavior, University of Florida","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Weiner","sequence":"additional","affiliation":[{"name":"NeuroPain Health","place":["Hollywood, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Howarth","sequence":"additional","affiliation":[{"name":"NeuroPain Health","place":["Hollywood, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenelle","family":"Becerra","sequence":"additional","affiliation":[{"name":"NeuroPain Health","place":["Hollywood, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo D.","family":"Fux","sequence":"additional","affiliation":[{"name":"NeuroPain Health","place":["Hollywood, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith S.","family":"Berry","sequence":"additional","affiliation":[{"name":"Department of Health Education and Behavior, University of Florida","place":["Gainesville, FL, United States"]},{"name":"Department of Psychology, University of Florida","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.15585\/mmwr.mm7215a1","article-title":"Chronic pain among adults\u2014United States, 2019\u20132021","volume":"72","author":"Rikard","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/j.pain.0000000000003056","article-title":"Co-occurrence of chronic pain and anxiety\/depression symptoms in U.S. adults: prevalence, functional impacts, and opportunities","volume":"165","author":"De La Rosa","year":"2024","journal-title":"Pain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1152\/physrev.00040.2019","article-title":"Cellular circuits in the brain and their modulation in acute and chronic pain","volume":"101","author":"Kuner","year":"2021","journal-title":"Physiol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1037\/0003-066X.59.8.795","article-title":"Comorbidity of chronic pain and mental health disorders: the biopsychosocial perspective","volume":"59","author":"Gatchel","year":"2004","journal-title":"Am Psychol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00296-016-3481-8","article-title":"An overview of treatment approaches for chronic pain management","volume":"37","author":"Hylands-White","year":"2017","journal-title":"Rheumatol Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/ejp.1561","article-title":"Necessary components of psychological treatment in pain management programs: a Delphi study","volume":"24","author":"Sharpe","year":"2020","journal-title":"Eur J Pain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/rapm-2020-101273","article-title":"Chronic pain and psychedelics: a review and proposed mechanism of action","volume":"45","author":"Castellanos","year":"2020","journal-title":"Reg Anesth Pain Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11916-024-01353-0","article-title":"Pain and perception: exploring psychedelics as novel therapeutic agents in chronic pain management","volume":"29","author":"Strand","year":"2025","journal-title":"Curr Pain Headache Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"172547","DOI":"10.1016\/j.ejphar.2019.172547","article-title":"Ketamine applications beyond anesthesia\u2014a literature review","volume":"860","author":"Nowacka","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.ajp.20240378","article-title":"Redefining ketamine pharmacology for antidepressant action: synergistic NMDA and opioid receptor interactions?","volume":"182","author":"Levinstein","year":"2025","journal-title":"Am J Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1124\/jpet.123.001823","article-title":"Ketamine\u2014a new antidepressant drug with anti-inflammatory properties","volume":"388","author":"J\u00f3\u017awiak-B\u0119benista","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am J Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14605","DOI":"10.3390\/ijms232314605","article-title":"The downstaging concept in treatment-resistant depression: spotlight on ketamine","volume":"23","author":"Wilkowska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/j.pain.0000000000002403","article-title":"Ketamine for refractory chronic pain: a 1-year follow-up study","volume":"163","author":"Corriger","year":"2022","journal-title":"Pain"},{"key":"B16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1213\/ANE.0000000000004185","article-title":"Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials","volume":"129","author":"Orhurhu","year":"2019","journal-title":"Anesth Analg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1192\/bjo.2021.1061","article-title":"Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review","volume":"8","author":"Walsh","year":"2022","journal-title":"BJPsych Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1176\/appi.ajp.21111086","article-title":"An update on community ketamine practices","volume":"179","author":"O\u2019Brien","year":"2022","journal-title":"Am J Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ejp.1914","article-title":"Ketamine in chronic pain: a Delphi survey","volume":"26","author":"Voute","year":"2022","journal-title":"Eur J Pain"},{"key":"B20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bcp.12094","article-title":"Ketamine for chronic pain: risks and benefits","volume":"77","author":"Niesters","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/17512433.2020.1717947","article-title":"Emerging concepts on the use of ketamine for chronic pain","volume":"13","author":"Yang","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e2314406","DOI":"10.1001\/jamanetworkopen.2023.14406","article-title":"Assessment of initial depressive state and pain relief with ketamine in patients with chronic refractory pain","volume":"6","author":"Voute","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2147\/JPR.S360733","article-title":"Ketamine assisted psychotherapy: a systematic narrative review of the literature","volume":"15","author":"Drozdz","year":"2022","journal-title":"J Pain Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000507095","article-title":"Continuous ketamine infusion for pain as an opportunity for psychotherapy for PTSD: a case series of ketamine-enhanced psychotherapy for PTSD and pain (KEP-P2)","volume":"89","author":"Keizer","year":"2020","journal-title":"Psychother Psychosom"},{"key":"B25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/papr.12829","article-title":"Ketamine and cognitive behavioral therapy for rapid opioid tapering with sustained opioid abstinence: a case report and 1-year follow-up","volume":"20","author":"Ocker","year":"2020","journal-title":"Pain Pract"},{"key":"B26","article-title":"Harm Related to Recreational Ketamine Use and Its Relevance for the Clinical Use of Ketamine","author":"Van Amsterdam","year":""},{"key":"B27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/ph13070151","article-title":"Safety of repeated administration of parenteral ketamine for depression","volume":"13","author":"Feifel","year":"2020","journal-title":"Pharmaceuticals"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1097\/PR9.0000000000000674","article-title":"Ketamine for pain management","volume":"3","author":"Bell","year":"2018","journal-title":"Pain Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1127863","DOI":"10.3389\/fpain.2023.1127863","article-title":"Ketamine-assisted psychotherapy treatment of chronic pain and comorbid depression: a pilot study of two approaches","volume":"4","author":"Batievsky","year":"2023","journal-title":"Front Pain Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamapsychiatry.2021.2669","article-title":"Effect of pain reprocessing therapy vs placebo and usual care for patients with chronic back pain: a randomized clinical trial","volume":"79","author":"Ashar","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"B31","volume-title":"Internal Family Systems Therapy","author":"Schwartz","year":"1995"},{"key":"B32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jts.2490020207","article-title":"Efficacy of the eye movement desensitization procedure in the treatment of traumatic memories","volume":"2","author":"Shapiro","year":"1989","journal-title":"J Trauma Stress"},{"key":"B33","doi-asserted-by":"publisher","first-page":"100572","DOI":"10.1016\/j.ejtd.2025.100572","article-title":"Self-reported improvements in comorbid post-traumatic stress disorder symptoms, depression, anxiety, and sleep among real-world patients receiving medical ketamine: exploring the role of adjunct therapies","volume":"9","author":"Almog","year":"2025","journal-title":"Eur J Trauma Dissociation"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1675821\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:37:47Z","timestamp":1771918667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1675821\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":33,"alternative-id":["10.3389\/fpain.2025.1675821"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2025.1675821","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"article-number":"1675821"}}